top of page

Bringing Light to Blind Medical Procedures

Epidural precision needle guidance system

Designed to meet
market needs

The BrightPointTM needle guidance system was designed to assist physicians with needle placement during epidural procedures for childbirth, spine/back pain and surgical procedures such as knee and hip replacements.

​

Designed to provide real-time visual guidance for training procedures with the aim to reduce the number of training procedures, the BrightPoint™ epidural system reduces complications and increases successful procedures.

Low Cost, Easy to Use Design

Design composed of a reusable handheld controller plus a single use, disposable fiber optic light channel designed to fit in the lumen of existing epidural needles.

Operates Based on the Changes in Light Reflection 

The color of the tissue at the tip of the needle is shown on the controller screen along with a scrolling line graph of the relative reflectance of the tissue at the tip of the needle.

Real-time Visual Guidance

Designed to provide real-time visual guidance for training procedures with the aim to reduce the number of training procedures, reduce complications and increase successful procedures.

Designed to be an Addition to Existing LOR Technology

The device is designed to be an addition to - not a replacement for - the manual (unguided) Loss of Resistance (LOR) method currently used by anesthesiologists. It does not require any changes to the LOR method and works with the current needles and syringes.

Statistic Snapshot of LOR Market

$5B

Spent annually on epidural procedures in the US

11M+

Epidural procedures performed annually in US

30M

Epidural procedures performed annually worldwide

9 M

Pain intervention steroid injections performed in the US

2.4 M

Labor procedures performed annually in the US

Bright Point Medical
Current Market Status

$1.5M

Current VC investments

Patients participated in our human clinical trials

156

Are You Ready to Fund the Future of Epidural Technology?

Bright Point represents a significant leap forward in needle placement, offering visual accuracy and sensitivity. Our early success in our human clinical trial is a major milestone for us. These initiatives represent not only our commitment to the forefront of women's health but also underscore the potential for transformative impact in needle guidance.

 

This device can potentially revolutionize how we approach needle guidance, making epidurals, pain management and so many more uses, more feasible, accessible, and effective globally. We believe that Bright Point will become the standard of care for Epidurals.

bottom of page